Hyrimoz

Active Ingredient(s): Adalimumab-adaz
FDA Approved: * October 30, 2018
Pharm Company: * SANDOZ INC
Category: Immunosuppressive

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Hyrimoz Overview

Adalimumab, is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFα).[5] It is sold under the brand name Humira, among others. It is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[6][7][8] Use...

Read more Hyrimoz Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Adalimumab

Recent Hyrimoz Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Adalimumab-adaz
  • Injection: 10mg/0.2ml, 20mg + 0.4ml, 20mg/0.4ml, 40mg/0.8ml
  • Syringe: 40mg/0.8ml
  • Vial: 40mg/0.8ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Adalimumab-adaz or a similar ingredient: (13 results)